Aarti Pharmalabs Ltd.
•₹ 816.8-1.5%
2026-08-21
PROS
- Latest quarter profit grew 39.2% YoY, showing strong momentum
- Operating margins have improved to 24.1% from 19.4%
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.17x)
- Company comfortably covers its interest (14.1x coverage)
- Company maintains a comfortable, low leverage position
- Attractively priced for its growth - PEG of 0.8
CONS
- Recent results are weak - TTM profit is down 24.6% versus prior year
- Promoter holding has decreased over last 2 years: -3.6pp
- Total debt has risen sharply - up 57.4% year on year
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | AARTIPHARM | 834.70 | 35.51 | 7569.04 | 0.42 | 761.43 | 1554.17 | 5357.97 | 1287.39 | 17.59 | 26.78 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 358 | 356 | 373 | 415 | 393 | 377 | 471 | 530 | 375 | 417 | 425 | 580 | 535 | |
| 281 | 282 | 285 | 307 | 310 | 293 | 356 | 389 | 280 | 343 | 322 | 463 | 441 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 5 | 0 | 0 | 6 | 2 | 3 | 12 | -0 | 2 | 3 | -0 | 11 | 3 |
| Interest | 4 | 4 | 4 | 4 | 4 | 5 | 10 | 6 | 7 | 11 | 13 | 17 | 13 |
| Depreciation | 15 | 16 | 17 | 17 | 18 | 19 | 21 | 21 | 23 | 25 | 29 | 28 | 30 |
| 62 | 54 | 67 | 91 | 63 | 63 | 96 | 114 | 67 | 42 | 59 | 83 | 96 | |
| Tax % | 23.34% | 22.10% | 28.54% | 30.96% | 25.43% | 24.59% | 23.56% | 21.73% | 23.75% | 25.83% | 25.16% | 24.89% | 25.90% |
| Net Profit | 48 | 42 | 48 | 63 | 47 | 48 | 74 | 89 | 51 | 31 | 44 | 62 | 71 |
| 5 | 5 | 5 | 7 | 5 | 5 | 8 | 10 | 6 | 3 | 5 | 7 | 1 | |
| Equity Capital | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 358
- 281
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 4
- Depreciation
- 15
- 62
- Tax %
- 23.34%
- Net Profit
- 48
- 5
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 356
- 282
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 4
- Depreciation
- 16
- 54
- Tax %
- 22.10%
- Net Profit
- 42
- 5
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 373
- 285
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 4
- Depreciation
- 17
- 67
- Tax %
- 28.54%
- Net Profit
- 48
- 5
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 415
- 307
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 4
- Depreciation
- 17
- 91
- Tax %
- 30.96%
- Net Profit
- 63
- 7
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 393
- 310
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 4
- Depreciation
- 18
- 63
- Tax %
- 25.43%
- Net Profit
- 47
- 5
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 377
- 293
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 5
- Depreciation
- 19
- 63
- Tax %
- 24.59%
- Net Profit
- 48
- 5
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 471
- 356
- Operating Profit
- —
- OPM %
- —
- Other Income
- 12
- Interest
- 10
- Depreciation
- 21
- 96
- Tax %
- 23.56%
- Net Profit
- 74
- 8
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 530
- 389
- Operating Profit
- —
- OPM %
- —
- Other Income
- -0
- Interest
- 6
- Depreciation
- 21
- 114
- Tax %
- 21.73%
- Net Profit
- 89
- 10
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 375
- 280
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 7
- Depreciation
- 23
- 67
- Tax %
- 23.75%
- Net Profit
- 51
- 6
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 417
- 343
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 11
- Depreciation
- 25
- 42
- Tax %
- 25.83%
- Net Profit
- 31
- 3
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 425
- 322
- Operating Profit
- —
- OPM %
- —
- Other Income
- -0
- Interest
- 13
- Depreciation
- 29
- 59
- Tax %
- 25.16%
- Net Profit
- 44
- 5
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 580
- 463
- Operating Profit
- —
- OPM %
- —
- Other Income
- 11
- Interest
- 17
- Depreciation
- 28
- 83
- Tax %
- 24.89%
- Net Profit
- 62
- 7
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 535
- 441
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 13
- Depreciation
- 30
- 96
- Tax %
- 25.90%
- Net Profit
- 71
- 1
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 0 | 0 | 941 | 1,511 | 1,502 | 1,771 | 1,957 | |
| 0 | 0 | 761 | 1,203 | 1,156 | 1,345 | 1,570 | |
| Operating Profit | -0 | -0 | 182 | 310 | 357 | 441 | — |
| OPM % | — | — | 19 | 20 | 24 | 25 | — |
| Other Income | 0 | 0 | 3 | 1 | 11 | 14 | 16 |
| Interest | 0 | 0 | 11 | 20 | 17 | 26 | 53 |
| Depreciation | 0 | 0 | 37 | 56 | 66 | 79 | 112 |
| -0 | -0 | 134 | 233 | 275 | 336 | 279 | |
| Tax % | 0 | 0 | 20 | 26 | 27 | 23 | 25 |
| Net Profit | -0 | -0 | 107 | 172 | 201 | 257 | 208 |
| EPS | -1 | -0 | 12 | 19 | 22 | 28 | — |
| Dividend Payout % | 0 | 0 | 0 | 11 | 14 | 18 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -1 | -0 | 4,269 | 19 | 22 | 28 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | -1 | -0 | 4,269 | 19 | 22 | 28 | — |
Mar 2020
- 0
- 0
- Operating Profit
- -0
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- -0
- Tax %
- 0
- Net Profit
- -0
- EPS
- -1
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -1
Mar 2021
- 0
- 0
- Operating Profit
- -0
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- -0
- Tax %
- 0
- Net Profit
- -0
- EPS
- -0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -0
Mar 2022
- 941
- 761
- Operating Profit
- 182
- OPM %
- 19
- Other Income
- 3
- Interest
- 11
- Depreciation
- 37
- 134
- Tax %
- 20
- Net Profit
- 107
- EPS
- 12
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4,269
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4,269
Mar 2023
- 1,511
- 1,203
- Operating Profit
- 310
- OPM %
- 20
- Other Income
- 1
- Interest
- 20
- Depreciation
- 56
- 233
- Tax %
- 26
- Net Profit
- 172
- EPS
- 19
- Dividend Payout %
- 11
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 19
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 19
Mar 2024
- 1,502
- 1,156
- Operating Profit
- 357
- OPM %
- 24
- Other Income
- 11
- Interest
- 17
- Depreciation
- 66
- 275
- Tax %
- 27
- Net Profit
- 201
- EPS
- 22
- Dividend Payout %
- 14
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 22
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 22
Mar 2025
- 1,771
- 1,345
- Operating Profit
- 441
- OPM %
- 25
- Other Income
- 14
- Interest
- 26
- Depreciation
- 79
- 336
- Tax %
- 23
- Net Profit
- 257
- EPS
- 28
- Dividend Payout %
- 18
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 28
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 28
TTM
- 1,957
- 1,570
- Operating Profit
- —
- OPM %
- —
- Other Income
- 16
- Interest
- 53
- Depreciation
- 112
- 279
- Tax %
- 25
- Net Profit
- 208
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 23%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 34%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 31%
- 1 Year:
- -1%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 11%
- 3 Years:
- 14%
- Last Year:
- 15%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| LIABILITIES | - | - | - | - |
| Equity Capital | 0 | 45 | 45 | 45 |
| 1,239 | 1,393 | 1,576 | 1,797 | |
| 325 | 207 | 251 | 291 | |
| Trade Payables | 132 | 212 | 255 | 249 |
| 132 | 119 | 170 | 341 | |
| Total Liabilities | 1,827 | 1,976 | 2,297 | 2,724 |
| ASSETS | - | - | - | - |
| 701 | 848 | 953 | 1,059 | |
| Capital Work in Progress | 165 | 62 | 78 | 301 |
| 40 | 55 | 62 | 57 | |
| 444 | 538 | 582 | 544 | |
| 0 | 0 | 449 | 553 | |
| Cash & Bank | 56 | 0 | 4 | 4 |
| 420 | 472 | 168 | 206 | |
| Total Assets | 1,827 | 1,976 | 2,297 | 2,724 |
| Total Debt | 325 | 207 | 251 | 395 |
| Net Working Capital | 409 | 502 | 578 | 590 |
| Contingent Liabilities | 0 | 0 | 0 | 7 |
| Book Value per Share | 49558.52 | 158.74 | 178.89 | 203.25 |
| Face Value | 10.00 | 5.00 | 5.00 | 5.00 |
| Total Debt | 325 | 207 | 251 | 395 |
| Net Working Capital | 409 | 502 | 578 | 590 |
| Contingent Liabilities | 0 | 0 | 0 | 7 |
| Book Value per Share | 49558.52 | 158.74 | 178.89 | 203.25 |
| Face Value | 10.00 | 5.00 | 5.00 | 5.00 |
Mar 2022
- Equity Capital
- 0
- 1,239
- 325
- Trade Payables
- 132
- 132
- Total Liabilities
- 1,827
- 701
- Capital Work in Progress
- 165
- 40
- 444
- 0
- Cash & Bank
- 56
- 420
- Total Assets
- 1,827
- Total Debt
- 325
- Net Working Capital
- 409
- Contingent Liabilities
- 0
- Book Value per Share
- 49558.52
- Face Value
- 10.00
- Total Debt
- 325
- Net Working Capital
- 409
- Contingent Liabilities
- 0
- Book Value per Share
- 49558.52
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 45
- 1,393
- 207
- Trade Payables
- 212
- 119
- Total Liabilities
- 1,976
- 848
- Capital Work in Progress
- 62
- 55
- 538
- 0
- Cash & Bank
- 0
- 472
- Total Assets
- 1,976
- Total Debt
- 207
- Net Working Capital
- 502
- Contingent Liabilities
- 0
- Book Value per Share
- 158.74
- Face Value
- 5.00
- Total Debt
- 207
- Net Working Capital
- 502
- Contingent Liabilities
- 0
- Book Value per Share
- 158.74
- Face Value
- 5.00
Mar 2024
- Equity Capital
- 45
- 1,576
- 251
- Trade Payables
- 255
- 170
- Total Liabilities
- 2,297
- 953
- Capital Work in Progress
- 78
- 62
- 582
- 449
- Cash & Bank
- 4
- 168
- Total Assets
- 2,297
- Total Debt
- 251
- Net Working Capital
- 578
- Contingent Liabilities
- 0
- Book Value per Share
- 178.89
- Face Value
- 5.00
- Total Debt
- 251
- Net Working Capital
- 578
- Contingent Liabilities
- 0
- Book Value per Share
- 178.89
- Face Value
- 5.00
Mar 2025
- Equity Capital
- 45
- 1,797
- 291
- Trade Payables
- 249
- 341
- Total Liabilities
- 2,724
- 1,059
- Capital Work in Progress
- 301
- 57
- 544
- 553
- Cash & Bank
- 4
- 206
- Total Assets
- 2,724
- Total Debt
- 395
- Net Working Capital
- 590
- Contingent Liabilities
- 7
- Book Value per Share
- 203.25
- Face Value
- 5.00
- Total Debt
- 395
- Net Working Capital
- 590
- Contingent Liabilities
- 7
- Book Value per Share
- 203.25
- Face Value
- 5.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| -0 | 0 | -65 | 216 | 184 | 340 | |
| Cash from Investing | 0 | 0 | -134 | -116 | -184 | -420 |
| Cash from Financing | 0 | 0 | 255 | -157 | 4 | 79 |
| 0 | 0 | 56 | -56 | 4 | -1 | |
| Free Cash Flow | -0 | 0 | -65 | 116 | -1 | -64 |
| OCF / Net Profit | 1.00 | -0.00 | -0.61 | 1.26 | 0.92 | 1.32 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | 0 |
| OCF / Net Profit | 1.00 | -0.00 | -0.61 | 1.26 | 0.92 | 1.32 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | 0 |
Mar 2020
- -0
- Cash from Investing
- 0
- Cash from Financing
- 0
- 0
- Free Cash Flow
- -0
- OCF / Net Profit
- 1.00
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.00
- Cumulative 5-Year FCF
- 0
Mar 2021
- 0
- Cash from Investing
- 0
- Cash from Financing
- 0
- 0
- Free Cash Flow
- 0
- OCF / Net Profit
- -0.00
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.00
- Cumulative 5-Year FCF
- 0
Mar 2022
- -65
- Cash from Investing
- -134
- Cash from Financing
- 255
- 56
- Free Cash Flow
- -65
- OCF / Net Profit
- -0.61
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.61
- Cumulative 5-Year FCF
- 0
Mar 2023
- 216
- Cash from Investing
- -116
- Cash from Financing
- -157
- -56
- Free Cash Flow
- 116
- OCF / Net Profit
- 1.26
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.26
- Cumulative 5-Year FCF
- 0
Mar 2024
- 184
- Cash from Investing
- -184
- Cash from Financing
- 4
- 4
- Free Cash Flow
- -1
- OCF / Net Profit
- 0.92
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.92
- Cumulative 5-Year FCF
- 0
Mar 2025
- 340
- Cash from Investing
- -420
- Cash from Financing
- 79
- -1
- Free Cash Flow
- -64
- OCF / Net Profit
- 1.32
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.32
- Cumulative 5-Year FCF
- 0
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - |
| EPS (₹) | -0.75 | -0.18 | 4269.05 | 18.95 | 22.14 | 28.39 |
| Book Value (₹) | 9.25 | 9.12 | 49558.52 | 158.74 | 178.89 | 203.25 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 2.00 | 3.00 | 5.00 |
| Cash EPS (₹) | -0.75 | -0.18 | 5758.37 | 25.10 | 29.42 | 37.12 |
| PROFITABILITY | - | - | - | - | - | - |
| Operating Margin % | 0.00% | 0.00% | 19.37% | 20.49% | 23.04% | 24.08% |
| Net Margin % | 0.00% | 0.00% | 11.34% | 11.36% | 13.36% | 14.53% |
| ROE % | -8.07% | -2.00% | 17.23% | 12.83% | 13.11% | 14.86% |
| ROCE % | -8.07% | -1.93% | 18.03% | 15.60% | 16.55% | 17.61% |
| -7.47% | -1.84% | 11.68% | 9.03% | 9.39% | 10.25% | |
| EFFICIENCY | - | - | - | - | - | - |
| Debtor Days | 0 | 0 | 118 | 82 | 100 | 103 |
| Inventory Days | 0 | 0 | 172 | 119 | 136 | 116 |
| Payable Days | 0 | 0 | 53 | 77 | 113 | 105 |
| 0 | 0 | 237 | 123 | 122 | 115 | |
| FINANCIAL HEALTH | - | - | - | - | - | - |
| Debt to Equity (x) | 0.00x | 0.08x | 0.26x | 0.14x | 0.15x | 0.21x |
| Interest Coverage (x) | 0.00x | 0.00x | 12.79x | 12.39x | 17.50x | 14.12x |
| 0.00x | 11.42x | 1.85x | 2.08x | 2.04x | 1.95x | |
| GROWTH | - | - | - | - | - | - |
| Revenue Growth % | 0.00% | 0.00% | 0.00% | 60.60% | -0.60% | 17.92% |
| Operating Profit Growth % | 0.00% | 75.37% | 0.00% | 69.84% | 15.36% | 23.48% |
| Net Profit Growth % | 0.00% | 75.37% | 0.00% | 60.90% | 16.84% | 28.26% |
| 0.00% | 0.00% | 0.00% | 0.00% | 16.84% | 28.25% | |
| VALUATION | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 19.65x | 26.36x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 2.43x | 3.68x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.69% | 0.67% |
| 0.00x | 0.00x | 0.00x | 0.00x | 11.73x | 16.27x |
Mar 2020
- EPS (₹)
- -0.75
- Book Value (₹)
- 9.25
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -0.75
- Operating Margin %
- 0.00%
- Net Margin %
- 0.00%
- ROE %
- -8.07%
- ROCE %
- -8.07%
- -7.47%
- Debtor Days
- 0
- Inventory Days
- 0
- Payable Days
- 0
- 0
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 0.00x
- 0.00x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- -0.18
- Book Value (₹)
- 9.12
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -0.18
- Operating Margin %
- 0.00%
- Net Margin %
- 0.00%
- ROE %
- -2.00%
- ROCE %
- -1.93%
- -1.84%
- Debtor Days
- 0
- Inventory Days
- 0
- Payable Days
- 0
- 0
- Debt to Equity (x)
- 0.08x
- Interest Coverage (x)
- 0.00x
- 11.42x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 75.37%
- Net Profit Growth %
- 75.37%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 4269.05
- Book Value (₹)
- 49558.52
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 5758.37
- Operating Margin %
- 19.37%
- Net Margin %
- 11.34%
- ROE %
- 17.23%
- ROCE %
- 18.03%
- 11.68%
- Debtor Days
- 118
- Inventory Days
- 172
- Payable Days
- 53
- 237
- Debt to Equity (x)
- 0.26x
- Interest Coverage (x)
- 12.79x
- 1.85x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 18.95
- Book Value (₹)
- 158.74
- Dividend per Share (₹)
- 2.00
- Cash EPS (₹)
- 25.10
- Operating Margin %
- 20.49%
- Net Margin %
- 11.36%
- ROE %
- 12.83%
- ROCE %
- 15.60%
- 9.03%
- Debtor Days
- 82
- Inventory Days
- 119
- Payable Days
- 77
- 123
- Debt to Equity (x)
- 0.14x
- Interest Coverage (x)
- 12.39x
- 2.08x
- Revenue Growth %
- 60.60%
- Operating Profit Growth %
- 69.84%
- Net Profit Growth %
- 60.90%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 22.14
- Book Value (₹)
- 178.89
- Dividend per Share (₹)
- 3.00
- Cash EPS (₹)
- 29.42
- Operating Margin %
- 23.04%
- Net Margin %
- 13.36%
- ROE %
- 13.11%
- ROCE %
- 16.55%
- 9.39%
- Debtor Days
- 100
- Inventory Days
- 136
- Payable Days
- 113
- 122
- Debt to Equity (x)
- 0.15x
- Interest Coverage (x)
- 17.50x
- 2.04x
- Revenue Growth %
- -0.60%
- Operating Profit Growth %
- 15.36%
- Net Profit Growth %
- 16.84%
- 16.84%
- P/E (x)
- 19.65x
- P/B (x)
- 2.43x
- Dividend Yield %
- 0.69%
- 11.73x
Mar 2025
- EPS (₹)
- 28.39
- Book Value (₹)
- 203.25
- Dividend per Share (₹)
- 5.00
- Cash EPS (₹)
- 37.12
- Operating Margin %
- 24.08%
- Net Margin %
- 14.53%
- ROE %
- 14.86%
- ROCE %
- 17.61%
- 10.25%
- Debtor Days
- 103
- Inventory Days
- 116
- Payable Days
- 105
- 115
- Debt to Equity (x)
- 0.21x
- Interest Coverage (x)
- 14.12x
- 1.95x
- Revenue Growth %
- 17.92%
- Operating Profit Growth %
- 23.48%
- Net Profit Growth %
- 28.26%
- 28.25%
- P/E (x)
- 26.36x
- P/B (x)
- 3.68x
- Dividend Yield %
- 0.67%
- 16.27x
Documents
Announcements
- Copy of Newspaper Publication
2026-08-18 - Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publication
- Record Date
2026-08-17 - Aarti Pharmalabs Limited has informed the Exchange that Record date for the purpose of Dividend is 15-Sep-2026.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Aug 2026
Jun 2026
May 2026